Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T72835 | Target Info | |||
Target Name | E-selectin (SELE) | ||||
Synonyms | Leukocyte-endothelial cell adhesion molecule 2; LECAM2; Endothelial leukocyte adhesion molecule 1; ELAM1; ELAM-1; CD62E antigen; CD62E; CD62 antigen-like family member E | ||||
Target Type | Clinical trial Target | ||||
Gene Name | SELE | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: (1R,2R,3S)-3-methylcyclohexane-1,2-diol | Ligand Info | |||||
Structure Description | E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic antagonist | PDB:4C16 | ||||
Method | X-ray diffraction | Resolution | 1.93 Å | Mutation | No | [1] |
PDB Sequence |
WSYNTSTEAM
10 TYDEASAYCQ20 QRYTHLVAIQ30 NKEEIEYLNS40 ILSYSPSYYW50 IGIRKVNNVW 60 VWVGTQKPLT70 EEAKNWAPGE80 PNNRQKDEDC90 VEIYIKREKD100 VGMWNDERCS 110 KKKLALCYTA120 ACTNTSCSGH130 GECVETINNY140 TCKCDPGFSG150 LKCEQIVNCT 160 ALESPEHGSL170 VCSHPLGNFS180 YNSSCSISCD190 RGYLPSSMET200 MQCMSSGEWS 210 APIPACNVVE220 CDAVTNPANG230 FVECFQNPGS240 FPWNTTCTFD250 CEEGFELMGA 260 QSLQCTSSGN270 WDNEKPTCKA280
|
|||||
|
||||||
Ligand Name: (S)-Cyclohexyl Lactic Acid | Ligand Info | |||||
Structure Description | E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic antagonist | PDB:4C16 | ||||
Method | X-ray diffraction | Resolution | 1.93 Å | Mutation | No | [1] |
PDB Sequence |
WSYNTSTEAM
10 TYDEASAYCQ20 QRYTHLVAIQ30 NKEEIEYLNS40 ILSYSPSYYW50 IGIRKVNNVW 60 VWVGTQKPLT70 EEAKNWAPGE80 PNNRQKDEDC90 VEIYIKREKD100 VGMWNDERCS 110 KKKLALCYTA120 ACTNTSCSGH130 GECVETINNY140 TCKCDPGFSG150 LKCEQIVNCT 160 ALESPEHGSL170 VCSHPLGNFS180 YNSSCSISCD190 RGYLPSSMET200 MQCMSSGEWS 210 APIPACNVVE220 CDAVTNPANG230 FVECFQNPGS240 FPWNTTCTFD250 CEEGFELMGA 260 QSLQCTSSGN270 WDNEKPTCKA280
|
|||||
|
||||||
Ligand Name: alpha-L-Fucose | Ligand Info | |||||
Structure Description | E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic antagonist | PDB:4C16 | ||||
Method | X-ray diffraction | Resolution | 1.93 Å | Mutation | No | [1] |
PDB Sequence |
WSYNTSTEAM
10 TYDEASAYCQ20 QRYTHLVAIQ30 NKEEIEYLNS40 ILSYSPSYYW50 IGIRKVNNVW 60 VWVGTQKPLT70 EEAKNWAPGE80 PNNRQKDEDC90 VEIYIKREKD100 VGMWNDERCS 110 KKKLALCYTA120 ACTNTSCSGH130 GECVETINNY140 TCKCDPGFSG150 LKCEQIVNCT 160 ALESPEHGSL170 VCSHPLGNFS180 YNSSCSISCD190 RGYLPSSMET200 MQCMSSGEWS 210 APIPACNVVE220 CDAVTNPANG230 FVECFQNPGS240 FPWNTTCTFD250 CEEGFELMGA 260 QSLQCTSSGN270 WDNEKPTCKA280
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .A:80 or .A:82 or .A:84 or .A:85 or .A:88 or .A:94 or .A:105 or .A:106 or .A:107 or .A:111; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: beta-D-galactose | Ligand Info | |||||
Structure Description | E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic antagonist | PDB:4C16 | ||||
Method | X-ray diffraction | Resolution | 1.93 Å | Mutation | No | [1] |
PDB Sequence |
WSYNTSTEAM
10 TYDEASAYCQ20 QRYTHLVAIQ30 NKEEIEYLNS40 ILSYSPSYYW50 IGIRKVNNVW 60 VWVGTQKPLT70 EEAKNWAPGE80 PNNRQKDEDC90 VEIYIKREKD100 VGMWNDERCS 110 KKKLALCYTA120 ACTNTSCSGH130 GECVETINNY140 TCKCDPGFSG150 LKCEQIVNCT 160 ALESPEHGSL170 VCSHPLGNFS180 YNSSCSISCD190 RGYLPSSMET200 MQCMSSGEWS 210 APIPACNVVE220 CDAVTNPANG230 FVECFQNPGS240 FPWNTTCTFD250 CEEGFELMGA 260 QSLQCTSSGN270 WDNEKPTCKA280
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GAL or .GAL2 or .GAL3 or :3GAL;style chemicals stick;color identity;select .A:46 or .A:47 or .A:48 or .A:92 or .A:94 or .A:97 or .A:105 or .A:107 or .A:113; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: (2~{R})-3-cyclohexyl-2-[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[(1~{R},2~{R})-2-[(2~{S},3~{S},4~{R},5~{S},6~{S})-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxycyclohexyl]oxy-3,5-bis(oxidanyl)oxan-4-yl]oxy-propanoic acid | Ligand Info | |||||
Structure Description | E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand BW69669 | PDB:6EYI | ||||
Method | X-ray diffraction | Resolution | 2.04 Å | Mutation | No | [2] |
PDB Sequence |
WSYNTSTEAM
10 TYDEASAYCQ20 QRYTHLVAIQ30 NKEEIEYLNS40 ILSYSPSYYW50 IGIRKVNNVW 60 VWVGTQKPLT70 EEAKNWAPGE80 PNNRQKDEDC90 VEIYIKREKD100 VGMWNDERCS 110 KKKLALCYTA120 ACTNTSCSGH130 GECVETINNY140 TCKCDPGFSG150 LKCEQIVNCT 160 ALESPEHGSL170 VCSHPLGNFS180 YNSSCSISCD190 RGYLPSSMET200 MQCMSSGEWS 210 APIPACNVVE220 CDAVTNPANG230 FVECFQNPGS240 FPWNTTCTFD250 CEEGFELMGA 260 QSLQCTSSGN270 WDNEKPTCKA280
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .C4Z or .C4Z2 or .C4Z3 or :3C4Z;style chemicals stick;color identity;select .A:44 or .A:46 or .A:47 or .A:48 or .A:80 or .A:82 or .A:84 or .A:85 or .A:88 or .A:92 or .A:94 or .A:97 or .A:98 or .A:105 or .A:106 or .A:107 or .A:113; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: (2~{S})-3-cyclohexyl-2-[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-3,5-bis(oxidanyl)-6-[(1~{R},2~{R})-2-[(2~{R},3~{S},4~{R},5~{S},6~{R})-3,4,5-tris(oxidanyl)-6-(trifluoromethyl)oxan-2-yl]oxycyclohexyl]oxy-oxan-4-yl]oxy-propanoic acid | Ligand Info | |||||
Structure Description | E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand NV354 | PDB:6EYJ | ||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | No | [3] |
PDB Sequence |
WSYNTSTEAM
10 TYDEASAYCQ20 QRYTHLVAIQ30 NKEEIEYLNS40 ILSYSPSYYW50 IGIRKVNNVW 60 VWVGTQKPLT70 EEAKNWAPGE80 PNNRQKDEDC90 VEIYIKREKD100 VGMWNDERCS 110 KKKLALCYTA120 ACTNTSCSGH130 GECVETINNY140 TCKCDPGFSG150 LKCEQIVNCT 160 ALESPEHGSL170 VCSHPLGNFS180 YNSSCSISCD190 RGYLPSSMET200 MQCMSSGEWS 210 APIPACNVVE220 CDAVTNPANG230 FVECFQNPGS240 FPWNTTCTFD250 CEEGFELMGA 260 QSLQCTSSGN270 WDNEKPTCKA280
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .C5H or .C5H2 or .C5H3 or :3C5H;style chemicals stick;color identity;select .A:44 or .A:46 or .A:47 or .A:48 or .A:80 or .A:82 or .A:84 or .A:85 or .A:88 or .A:92 or .A:94 or .A:97 or .A:105 or .A:106 or .A:107 or .A:113; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: (2~{S})-3-cyclohexyl-2-[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[(1~{R},2~{R},3~{S})-3-methyl-2-[(2~{R},3~{S},4~{R},5~{S},6~{R})-3,4,5-tris(oxidanyl)-6-(trifluoromethyl)oxan-2-yl]oxy-cyclohexyl]oxy-3,5-bis(oxidanyl)oxan-4-yl]oxy-propanoic acid | Ligand Info | |||||
Structure Description | E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand NV355 | PDB:6EYK | ||||
Method | X-ray diffraction | Resolution | 2.21 Å | Mutation | No | [4] |
PDB Sequence |
WSYNTSTEAM
10 TYDEASAYCQ20 QRYTHLVAIQ30 NKEEIEYLNS40 ILSYSPSYYW50 IGIRKVNNVW 60 VWVGTQKPLT70 EEAKNWAPGE80 PNNRQKDEDC90 VEIYIKREKD100 VGMWNDERCS 110 KKKLALCYTA120 ACTNTSCSGH130 GECVETINNY140 TCKCDPGFSG150 LKCEQIVNCT 160 ALESPEHGSL170 VCSHPLGNFS180 YNSSCSISCD190 RGYLPSSMET200 MQCMSSGEWS 210 APIPACNVVE220 CDAVTNPANG230 FVECFQNPGS240 FPWNTTCTFD250 CEEGFELMGA 260 QSLQCTSSGN270 WDNEKPTCKA280
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .C5K or .C5K2 or .C5K3 or :3C5K;style chemicals stick;color identity;select .A:44 or .A:46 or .A:47 or .A:48 or .A:80 or .A:82 or .A:84 or .A:85 or .A:88 or .A:92 or .A:94 or .A:97 or .A:98 or .A:99 or .A:105 or .A:106 or .A:107 or .A:113; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | E-selectin ligand complexes adopt an extended high-affinity conformation. J Mol Cell Biol. 2016 Feb;8(1):62-72. | ||||
REF 2 | E-selectin lectin with different glycomimetic ligands | ||||
REF 3 | E-selectin lectin with different glycomimetic ligands | ||||
REF 4 | E-selectin lectin with different glycomimetic ligands |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.